MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

5.35 -8.86

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.27

Max

5.85

Schlüsselkennzahlen
By Trading Economics
Einkommen	-2.3M -14M
Verkäufe	108K 19M
Gewinnspanne	-74.857
Angestellte	260
EBITDA	-9.9M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+157.99% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Aug. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-100M 143M
Vorheriger Eröffnungskurs	14.21
Vorheriger Schlusskurs	5.35

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Juli 2025, 22:07 UTC

Wichtige Markttreiber

Trade Desk Rises on S&P 500 Inclusion

14. Juli 2025, 17:06 UTC

Wichtige Markttreiber

Crypto Assets Rally Ahead of Possible U.S. Legislation

14. Juli 2025, 16:47 UTC

Akquisitionen, Fusionen, Übernahmen

NatWest to Sell Stake in Permanent TSB

14. Juli 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14. Juli 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14. Juli 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14. Juli 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14. Juli 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14. Juli 2025, 23:02 UTC

Ergebnisse

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14. Juli 2025, 23:02 UTC

Ergebnisse

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14. Juli 2025, 23:02 UTC

Ergebnisse

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14. Juli 2025, 23:01 UTC

Ergebnisse

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14. Juli 2025, 23:01 UTC

Ergebnisse

China Vanke Expects 1H Loss to Widen >000002.SZ

14. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. Juli 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14. Juli 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14. Juli 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14. Juli 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14. Juli 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14. Juli 2025, 18:30 UTC

Akquisitionen, Fusionen, Übernahmen

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14. Juli 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14. Juli 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14. Juli 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14. Juli 2025, 16:53 UTC

Heiße Aktien

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14. Juli 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14. Juli 2025, 16:20 UTC

Market Talk

Ergebnisse

Auto & Transport Roundup: Market Talk

14. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14. Juli 2025, 16:12 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

157.99% Vorteil

12-Monats-Prognose

Durchschnitt 15.17 USD 157.99%

Hoch 19 USD

Tief 12.5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.